Pierre Laneuville
Associate Professor (GFT-U) in the Department of Medicine and Oncology at 9I制作厂免费, the former Head of Hematology for the 9I制作厂免费 Health Center (MUHC).
Dr. Laneuville obtained an Honours B.Sc. in Biochemistry at McMaster University, his medical degree at the University of Ottawa, trained in internal Medicine at 9I制作厂免费, and completed his hematology sub-specialty and research training with Dr. B.A. Cooper at the Royal Victoria Hospital and 9I制作厂免费 from 1985 to 1989. He then joined the staff and faculty at the Royal Victoria Hospital and 9I制作厂免费 and has focused his clinical and laboratory research activities on hematological malignancies. 聽Dr. Laneuville is best known for his research on the molecular mechanisms underlying the genesis and transformation of chronic myelogenous leukemia. 聽
He is a past President of the Canadian Hematological Society and Chairman of the Canadian Consensus Group on the Management of Chronic Myeloid Leukemia (CCGM-CML). 聽He has served on numerous basic and clinical research panels including the Medical Research Council of Canada, the Leukemia Research Fund of Canada, and the National Cancer Institute of Canada Clinical Trials Hematology Executive. 聽
He has held a number of research grants supported by the MRC, LRFC, CRSI, MSSC, and is actively engaged in clinical trials for hematological malignancies and stem cell transplantation. He is currently the Medical Director of the 9I制作厂免费 Health Centre Research Institute Cellular Therapy Laboratory.